Skip to content

Merck stops development of CCR5 inhibitor vicriviroc

Maraviroc potentially useful if neurological disease is present

Towards more compassionate care for people with drug-resistant TB

UNAIDS calls for radical simplification of treatment to support HIV prevention

HIV cure efforts severely underfunded, US activists report

CD4 cell count below 500 associated with increased risk of CVD - implications for 'when to start' debate

Kidney disease increases mortality for women with AIDS starting HIV treatment

Atazanavir for children approved in European Union

Expanding coverage of HIV therapy is highly cost-effective, and could prevent many new infections